Quantitative approaches to drug development

Quantitative approaches to drug development

We provide consultancy services to help our clients reduce uncertainty in research and regulatory questions, increasing confidence in the development of new medicines that can improve patients’ lives.

Science and Services

About

News

15.03.2024
New Publication: Bioavailability of three novel oral, sustained-release pellets, relative to an immediate-release tablet containing 500 mg flucytosine: A randomized, open-label, crossover study in healthy volunteers

A publication about formulation and dose selection for further clinical development of a sustained release formulation in the treatment of cryptococcal meningoencephalitis.  This research contributes to combating infectious diseases, and by innovative formulations and optimization of dosing, aim to enhance treatment accessibility and efficacy, ultimately improving lives of those affected by cryptococcal meningoencephalitis.

07.03.2024
Pharmetheus appoints Regulatory Affairs Consultant

Dr. Tomas Salmonson, a Pharmetheus board member who has chaired the Committee for Medicinal Products for Human Use, CHMP, at the European Medicines Agency (EMA), comments: – Regulatory strategy is becoming increasingly crucial to bring new drugs to market. The main responsibilities of this role are to monitor and report regulatory news, analyze changes and recommend actions, and to enable…

05.03.2024
New Publication: Using forest plots to interpret covariate effects in pharmacometric models

A tutorial addressing the important and complicated challenge of communicating the impact of covariates, aiming to facilitate the collaboration by discussing the various aspects to keep in mind, and supplying checklists for both the creator and the receiver of the forest plots, as well as suggesting a structured way of formulating informative figure captions.

How we work

Explore our web

Model Informed Drug Development

A quantitative framework to support and inform development program strategies and decisions.

Read more

“Sharing with colleagues is why I love working here”

Sophie Peigné supports clients with expert and strategic advice in pharmacometrics as well as hands-on modeling analyses for compounds in all development phases.

Read more

History of Pharmetheus

Our journey is an exciting one. We began as a start-up that spinned off from Uppsala University. Today, we have grown into a global medium-sized company, adding value to drug development each day.

Read more